Pfizer says that Lipitor's growth alone will outweigh the loss of an antifungal drug, Diflucan, to patent expiration.

FORBES: Pfizer's Tough Transition

Wyeth scientists originally hoped rapamycin could become an antifungal drug.

FORBES: Health

Versicor brought to the table a host of interesting programs early in the research pipeline and an antifungal drug, anidulafungin, which is now being evaluated by the FDA to treat invasive fungal infections that can damage the internal organs of patients with already compromised immune systems.

FORBES: Building An Antibiotic Powerhouse

The U.S. Food and Drug Administration is likely to make a regulatory decision on its antifungal medicine, andulafungin, by May 25.

FORBES: Building A Better Bacteria Killer